Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza.
about
Exploiting Genetic Interference for Antiviral TherapyAntivirals in the 2009 pandemic--lessons and implications for future strategies.Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunologyOseltamivir for influenza infection in children: risks and benefits.Pharmacokinetics of oseltamivir in infants under the age of 1 year.Guidance on the use of antiviral drugs for influenza in acute care facilities in Canada, 2014-2015.A prospective observational study of oseltamivir safety and tolerability in infants and young children ≤24 months.The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach.Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS).Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials.
P2860
Q24288775-BF684A7B-B7FB-4D9C-9753-C37564DDA108Q30219151-90289CBB-0B31-4803-9AE4-9DE7F0FEBE54Q33827819-FA04AA23-C861-452B-ADF7-E6811FC7A5DEQ38652336-B64B72F0-292A-4DA6-831E-79572C142C37Q39421486-85394643-F1EF-48D9-A49C-638623C08743Q41395483-12AA47EB-217D-45B4-B2FB-D92E659B2A55Q41694420-42E955F2-5058-4E33-A7BA-98DDC8E3D94DQ42216493-1A188B16-77F1-4FFF-BC5F-A3EC89EA01C6Q44805348-7A37407A-86CB-4871-9D3E-CD5B9068D087Q47397356-59D68EB5-3291-4B6D-92F0-C862CE6C4773
P2860
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Oseltamivir pharmacokinetics, ...... aged <2 years with influenza.
@ast
Oseltamivir pharmacokinetics, ...... aged <2 years with influenza.
@en
type
label
Oseltamivir pharmacokinetics, ...... aged <2 years with influenza.
@ast
Oseltamivir pharmacokinetics, ...... aged <2 years with influenza.
@en
prefLabel
Oseltamivir pharmacokinetics, ...... aged <2 years with influenza.
@ast
Oseltamivir pharmacokinetics, ...... aged <2 years with influenza.
@en
P2093
P2860
P356
P1476
Oseltamivir pharmacokinetics, ...... aged <2 years with influenza.
@en
P2093
David Lang
David W Kimberlin
Edward P Acosta
Fred D Lakeman
Gretchen Cloud
Janet A Englund
John A Vanchiere
John S Bradley
Krow Ampofo
P2860
P304
P356
10.1093/INFDIS/JIS765
P407
P577
2012-12-10T00:00:00Z